Optiscan Imaging LimitedASX: OIL

Appendix 4D

· Issued by Optiscan Imaging Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

The report indicates a significant decrease in revenue and an increase in losses compared to the previous period, primarily due to reduced sales of its life sciences research device. The company reported no dividends paid or declared during the current financial period, and its net assets increased significantly due to a recent capital raise. The financial position shows a strong working capital surplus, with cash reserves bolstered by the capital raised for clinical studies and regulatory submissions.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Optiscan Imaging Limited on 6ix

Earlier from Optiscan Imaging

Later from Optiscan Imaging

All Optiscan Imaging news releases